Seminar Series Schedule 2010
January 28 - 4:00 PM - Joe D'Silva, PhD (Founder & CEO, Patients' and Consumers' Pharma)*
"Designing Pharmaceutical Products for Personalized Medicine"
February 4 -11:00 AM - Susan Weiss, PhD (University of Pennyslvania School of Medicine)
"Murine Coronavirus CNS Pathogenesis: Host-Virus Interaction"
March 8 - 11:00 AM - Michael Kurilla, MD, PhD* (DMID, NIAID, NIH, DHHS)
"Product Development Resrouces Through the National Institute of Allergy and Infectious Diseases"
March 10 - 11:00 AM - Robert Perrillo, MD (Baylor University Medical Center
"Antiviral Therapy of Hepatitis B: Progress and Problems"
March 25 - 11:00 AM - Robert Raffa, PhD** with Scott Rawls, PhD (Temple University School of Medicine)
"Planaria: A Model for Drug Action and Screen for CNS-Active Therapeutics "
April 1 - 4:00 PM - T. Jake Liang, MD (National Institute of Diabetes and Digestive and Kidney Diseases, NIH)
"Choreographing the Tango Between Hepatitis C Virus and Cells by Functional Genomic Screen"
Hepatitis B Foundation's 2010 Bruce Witte Lecturer
April 9 - 4:00 PM - R. Palmer Beasley, MD (University of Texas School of Public Health)
"HBV - The First Zoonosis?
Hepatitis B Foundation's 2010 Distinguished Scientist
April 15 - 11:00 AM - Claus Fimmel, MD (Loyola University Medical Center)
"Liver Cancer and Golgi Proteins - The Ups and Downs of GP73"
April 19 - 11:00 AM - John S. Lazo, PhD** (University of Pittsburgh)
"How to Target Pennsylvania as the Center for Drug Discovery and Development"
April 21 - TBD - Eiji Miyoshi, PhD (Osaka University Graduate School of Medicine)
"Fucosylation is a Promising Target for Cancer"
April 27 - 4:00 PM - Edward Griffith* (Product and Educational Services, LLC)
"Management Principles for Scientists and Entrepreneurs"
May 6 - 4:00 PM - Patrick Chaltin, PhD (Katholieke Universiteit Leuven)
"CD3, Stimulating Innovative Small Molecule Drug Discovery"
May 10 - 11:00 AM - Stephen Goff, PhD (Columbia University)
"Innate Defenses and Viral Infections"
May 13 - 11:00 AM - Greg Burdea, PhD** (Rutgers University)
"Avatars, Games and Clouds -- The Future of Therapy, Today"
May 20 - 11:00 AM - Donna Huryn, PhD** (University of Pennsylvania)
"Using Chemistry to Answer Biological Questions: Small Molecule Probes of Tau, Hsp70 and Cathepsins"
May 21 - 11:00 AM - Ralf Bartenschlager, PhD (University Heidelberg)
"New Insights Into Hepatitis C Virus Replication and Persistence"
June 3 - 11:00 AM - Eileen Jaffe, PhD** (Fox Chase Cancer Center)
"Morpheeins - A New Pathway for Drug Discovery"
June 10 - 11:00 AM - Martin Pomper, MD, PhD** (Johns Hopkins Medical Institutions)
"Translational Molecular Imaging"
June 17 - 11:00 AM - Richard Sifers, PhD (Baylor College of Medicine)
"Glycan-Directed Protein Biosynthetic Quality Control in the Secretory Pathway"
June 21 - 11:00 AM - Prof. Chris McGuigan (Welsh School of Pharmacy, Cardiff University)
"New Drug Discovery for Viruses and Cancer"
June 23 - 4:00 PM - Sri Srivastava, PhD* (ClinTech Research, LLC)
"Preclinical Drug Development and Outsourcing Challenges"
July 22 - 11:00 AM - Fred Krebs, PhD (Drexel University College of Medicine)
"Research in Isolation: Working Safely and Effectively in a Biosafety Level 3 Environment"
July 29 - 11:00 AM - Brendan J. Canning, PhD** (Johns Hopkins Asthma and Allergy Center)
"Cough: Novel Therapeutic Strategies For An Unmet Medical Need"
August 12 - 11:00 AM - Jumin Zhou, PhD (The Wistar Institute)
"Understanding the Epigenome Through Specialized DNA Elements"
August 26 - 11:00 AM - Johnny J. He, PhD (Indiana University School of Medicine)
"Host Control of HIV-1 Replication: A Sam68 Story"
August 31 - 11:00 AM - Chen Liu, MD, PhD (University of Florida)
"Induction of Apoptosis for Liver Cancer Therapy"
September 16 - 11:00 AM - Thomas Shenk, PhD (Princeton University)
"Human Cytomegalovirus Replication and Pathogenesis"
Distinguished Speaker Series
September 20 - 11:00 AM - Peter Katsikis, MD, PhD (Drexel University College of Medicine)
"Phosphorothioate Oligomers as Novel HIV Microbicides with Both Anti-viral and TLR Inhibitory Activity"
September 28 - 11:00 AM - Erik M. Schwiebert, PhD** (Discovery BioMed)
"Integrating Human Cell Physiology with Drug Discovery"
October 1 - 8:30 AM - 1:00 PM - Annual Biotech Conference* (Regional Biotech Council)
To Register Please Visit http://www.ihvr.org/rbc/index.htm
October 8 - 11:00 AM - Anna Proietti, MD, PhD (Fundacao Hemominas)
"HTLV Cohort Study in Belo Horizonte, Brazil: 13 Years of Follow-up"
October 15 - 1:30 PM - Chun-wa Chung, PhD** (GlaxoSmithKline)
"Epigenetic Targets in Drug Discovery: Potent, Selective Inhibitors of BET Family Bromodomains as Modulators of Histone Code Expression"
October 21 - 11:00 AM - Osvaldo (Lalo) Flores, PhD (Novira Therapeutics)
"Discovery of Novel Drug Candidates That Disrupt HIV and HBV Virus Assembly"
November 4 - 11:00 AM - Todd Margolis, MD, PhD (University of California, San Francisco)
"Establishment of HSV Latent Infection"
November 11 - 11:00 AM - Julie Margarian Blander, PhD (Mount Sinai School of Medicine)
"Apoptosis and TH17 Cell Differentiation"
November 17 - 11:00 AM - Kelly Stefano Cole, PhD (University of Pittsburgh)
"Preclinical Studies With Emerging Pathogens in the University of Pittsburgh RBL"
November 29 - 11:00 AM - David B. Weiner, PhD (University of Pennsylvania)
"Engineering a New Generation of DNA Vaccines For Difficult Pathogens"
December 2 - 4:00 PM - Ted Torphy, PhD* (Johnson & Johnson)
"The Disintegration of Large Pharma: An Opportunity toTransform Our Industry"
December 16 - 11:00 AM - Jianming Hu, MD, PhD (Pennsylvania State University College of Medicine)
"Hepatitis B Virus Molecular Biology"
*Regional Biotech Council (RBC) Seminar Speakers (Registration may be required)
**Pennsylvania Drug Discovery Institute Seminar Speakers